A recombinant adenoviral vector encoding functional vasoactive intestinal peptide

Biochemical and Biophysical Research Communications

Volumn 319, Issue 1, 2004, Pages 189-192

  Lodde, B M ^a,b   Delporte, C ^c   Goldsmith, C M ^a   Tak, P P ^b   Baum, B J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Adenovirus; Autoimmune disease; Gene transfer; Vasoactive intestinal peptide

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC AMP; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; DOSE RESPONSE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KIDNEY CELL; MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; BRAIN; CELL LINE; CULTURE MEDIA; CYCLIC AMP; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSGENES; VASOACTIVE INTESTINAL PEPTIDE;

ADENOVIRIDAE;

EID: 2442701284     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.171     Document Type: Article

References (27)

1. Said S.I. Vasocative intestinal peptide. J. Endocrinol. 9:1986;191-200
2. Firestein G.S. VIP: A very important protein in arthritis. Nat. Med. 7:2001;5378
3. Delgado M., Abad C., Martinez C., Leceta J., Gomariz R.P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7:2001;563-568
4. Ekström J. Autonomic control of salivary secretion. Proc. Finn. Dent. Soc. 85:1989;323-331
5. Ekström J., Ekström P.F. Acinar degranulation in the rat parotid gland induced by neuropeptides. Exp. Physiol. 86:2001;733-738
6. Krishnadas A., Önyüksel H., Rubinstein I. Interactions of VIP, secretin and PACAP1-38 with phospholipids: a biological paradox revisited. Curr. Pharm. Des. 9:2003;1005-1012
7. Park S.K., O'Dorisio M.S., O'Dorisio T.M. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy. Baillières Clin. Gastroenterol. 10:1996;673-696
8. Baum B.J., Wellner R.B., Zheng C. Gene transfer to salivary glands. Int. Rev. Cytol. 213:2002;93-146
9. Delporte C., O'Connell B.C., He X., Lancaster H.E., O'Connell A.C., Agre P., Baum B.J. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc. Natl. Acad. Sci. USA. 94:1997;3268-3273
10. Shetzline M.A., Walker J.K., Valenzano K.J., Premont R.T. Vasoactive intestinal polypeptide type-1 receptor regulation. Desensitization, phosphorylation, and sequestration. J. Biol. Chem. 277:2002;25519-25526
11. 1 receptor. Peptides. 18:1997;1555-1560
12. Williams R.O. Therapeutic effect of vasoactive intestinal peptide in collagen-induced arthritis. Arthritis Rheum. 46:2002;271-273
13. Delgado M., Abad C., Martinez C., Juarranz M.G., Arranz A., Gomariz R.P., Leceta J. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med. 80:2002;16-24
14. Kato I., Suzuki Y., Akabane A., Yonekura H., Tanaka O., Kondo H., Takasawa S., Yoshimoto T., Okamoto H. Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic β cells. J. Biol. Chem. 269:1994;21223-21228
15. Itoh N., Obata K., Yanaihara N., Okamoto H. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27. Nature. 304:1983;547-549
16. Gozes I., Avidor R., Yahav Y., Katznelson D., Croce C.M., Huebner K. The gene encoding vasoactive intestinal peptide is located on human chromosome 6p21-6qter. Hum. Genet. 75:1987;41-44
17. Yamagami T., Ohsawa K., Nishizawa M., Inoue C., Gotoh E., Yanaihara N., Yamamoto H., Okamoto H. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter. Ann. N. Y. Acad. Sci. 527:1988;87-102
18. Steiner D.F., Quinn P.S., Chan S.J., Marsh J., Tager H.S. Processing mechanisms in the biosynthesis of proteins. Ann. N. Y. Acad. Sci. 343:1980;1-16
19. Mains R.E., Eipper B.A. Post-translational processing of neuropeptide precursors. NIDA Res. Monogr. 54:1984;168-183
20. Eipper B.A., Mains R.E. Peptide α-amidation. Ann. Rev. Physiol. 50:1988;333-344
21. Eipper B.A., Green C.B., Mains R.E. Expression of prohormone processing enzymes in neuroendocrine and non-neuroendocrine cells. J. Natl. Cancer Inst. Monogr. 13:1992;163-168
22. Simoncsits A., Tjornhammar M.L., Kalman M., Cserpan I., Gafvelina G., Bartfai T. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide. Eur. J. Biochem. 178:1988;343-350
23. Gafvelin G., Andersson M., Dimaline R., Jornvall H., Mutt V. Isolation and characterization of a variant form of vasoactive intestinal polypeptide. Peptides. 9:1988;469-474
24. Shields P.P., Gibson T.R., Glembotski C.C. Ascorbate transport by AtT20 mouse pituitary corticotropic tumor cells: uptake and secretion studies. Endocrinology. 118:1986;1452-1460
25. Tausk F.A., Milgram S.L., Mains R.E., Eipper B.A. Expression of a peptide processing enzyme in cultured cells: truncation mutants reveal a routing domain. Mol. Endocrinol. 6:1992;2185-2196
26. Pozo D., Delgado M., Martinez M., Guerrero J.M., Leceta J., Gomariz R.P., Calvo J.R. Immunobiology of vasoactive intestinal peptide (VIP). Immunol. Today. 21:2000;7-11
27. Grimm M.C., Newman R., Hassim Z., Cuan N., Connor S.J., Le Y., Wang J.M., Oppenheim J.J., Lloyd A.R. Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J. Immunol. 171:2003;4990-4994